The potential underlying mechanisms were also preliminarily uncovered, and previous literatures report that p53 is the hub gene for regulating paclitaxel chemo-resistance (45, 46), and p53 can be targeted and degraded by gp96 (47), which encouraged us to assume that gp96 might regulate BC cell death through modulating p53. This evidence concerns the gene TP53 and breast cancer.